Search Results 531-540 of 6000 for albumin

  1. Detection and Identification of Bacterial and Fungal DNA in Blood - Mayo Clinic

    This study includes collection of blood samples from the healthy controls and those with suspected bloodstream infections. Participation eligibility.

  2. Untitled

    Page 1. Page 2.

  3. Anesthesiology and Perioperative Medicine - Clinical trials

    Mayo Clinic's Department of Anesthesiology sees more than 145000 patients each year and integrates patient care, research and education, resulting in ...

  4. https://www.mayoclinic.org/patient_consumer_video.xml

  5. Study to Evaluate the Efficacy and Safety of Lutathera in Patients with Grade 2 and Grade 3 Advanced GEP-NET - Mayo Clinic

    Serum albumin < 3.0 g/dL unless prothrombin time is within the normal range. Pregnancy or lactation. Women of child-bearing potential, defined as all women ...

  6. https://www.mayoclinic.org/patient_consumer_faq.xml

  7. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

    Albumin ≥ 2.5 mg/dL. Willing and able to comply with all aspects of the protocol. Provide written informed consent prior to any study-specific Screening ...

  8. Collection of Prospective Kidney Biospecimens for New Technology and Platform Development - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Study of Cell-surface Proteins in Renal Tumors for Future Exploration of New Anticancer Therapies - Mayo Clinic

    These therapeutic antibodies and their derivatives have transformed the therapeutic landscape of cancer patients. Only 20% of cell-surface proteins have been ...

  10. Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days - Mayo Clinic

    About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...